OGA and tauopathy: Of note, Thiamet-G and its derivative MK-8719, two OGA inhibitors that can cross the blood-brain barrier in vivo (Rostgaard et al. 2023; Wang et al. 2020), have been proven to be effective for the treatment of tauopathies.